Healthcare Services

Global Antimicrobial Resistance (AMR) Genotyping Panels Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Antimicrobial Resistance (AMR) Genotyping Panels Market By 2030 Starting From Its 2026 Size?

The antimicrobial resistance (amr) genotyping panels market has experienced rapid expansion in recent years. It is anticipated to increase from $1.45 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. This historical growth can be attributed to the rising occurrence of antimicrobial resistance, a greater incidence of hospital-acquired infections, the advancement of molecular diagnostic capabilities, increased understanding of resistance monitoring, and the accessibility of sophisticated genotyping technologies.

The market for antimicrobial resistance (amr) genotyping panels is projected to experience swift expansion in the coming years. This market is anticipated to reach $2.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. Factors driving this growth during the forecast period include greater investments in infectious disease diagnostics, a surge in demand for swift point-of-care testing, the broadening of genomic epidemiology programs, the expanding integration of amr data analytics, and an intensified regulatory emphasis on resistance surveillance. Key trends expected over the forecast horizon encompass the increased uptake of multiplex resistance detection panels, a growing reliance on rapid molecular diagnostics, the expanding incorporation of genomic surveillance tools, an enlargement of hospital-based amr testing initiatives, and a heightened emphasis on identifying resistance at early stages.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30196&type=smp

Which Market Drivers Are Supporting The Expansion Of The Antimicrobial Resistance (AMR) Genotyping Panels Market?

The increasing occurrence of infections resistant to antimicrobials is projected to fuel the expansion of the antimicrobial resistance (AMR) genotyping panels market in the future. Such infections are defined as illnesses originating from microorganisms, including bacteria, viruses, fungi, or parasites, which have developed resistance to the efficacy of conventional antimicrobial medications, consequently complicating their treatment. Among the elements contributing to the rise in antimicrobial resistance are the excessive and improper administration of antibiotics. Such practices have hastened the appearance of resilient pathogens, thereby stimulating the need for antimicrobial resistance (AMR) genotyping panels capable of quickly detecting resistance genes and directing precise antimicrobial interventions. As an illustration, data from the Centers for Disease Control and Prevention (CDC) indicates that over 2.8 million antimicrobial-resistant infections manifest annually in the US. Consequently, the escalating incidence of antimicrobial-resistant infections is propelling the expansion of the antimicrobial resistance (AMR) genotyping panels market.

Which Segment Categories Define The Antimicrobial Resistance (AMR) Genotyping Panels Market?

The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –

1) By Product Type: Custom Panels, Pre-Designed Panels

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies

3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users

Subsegments:

1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels

2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels

Which Trends Are Shaping The Future Of The Antimicrobial Resistance (AMR) Genotyping Panels Market?

Leading companies active in the antimicrobial resistance (AMR) genotyping panels market are prioritizing the creation of innovative products, such as multiplex PCR-based research assays, to allow for the concurrent detection of multiple pathogens and antibiotic resistance genes within a single analysis, thereby boosting research efficiency and aiding quicker identification of emerging resistance patterns. Multiplex PCR-based research assays are molecular tests designed to amplify and identify numerous genetic targets simultaneously to pinpoint pathogens and antibiotic resistance genes in a solitary reaction. For example, in September 2025, Molecular Designs, a US-based firm specializing in molecular diagnostics and research assays, launched the Urogenital Microbiota with ABX 53 Simplicity Panel, which is a multiplex PCR-based research assay tailored to detect urinary pathogens and antibiotic resistance genes in a single examination. This panel enables the simultaneous identification of 28 urogenital and urinary microbial targets (consisting of 20 bacterial, 7 fungal, and 1 protozoan) alongside 25 antibiotic-resistance gene markers, offering same-day results and being available in both 96-well and 384-well plate formats, with the 96-well version incorporating breakaway panels to reduce wastage.

Who Are The Top Companies Competing In The Antimicrobial Resistance (AMR) Genotyping Panels Market?

Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.

Read the full antimicrobial resistance (amr) genotyping panels market report here:

https://www.thebusinessresearchcompany.com/report/global-antimicrobial-resistance-amr-genotyping-panels-market-report

How Is The Antimicrobial Resistance (AMR) Genotyping Panels Market Distributed Across Key Geographic Regions?

North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antimicrobial Resistance (AMR) Genotyping Panels Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30196&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance (AMR) Genotyping Panels Market 2026, By The Business Research Company

Biomaterial Wound Dressing Global Market Report

https://www.thebusinessresearchcompany.com/report/biomaterial-wound-dressing-global-market-report

Preoperative Infection Prevention And Wound Cleansing Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/preoperative-infection-prevention-and-wound-cleansing-devices-global-market-report

Topical Wound Agents Global Market Report

https://www.thebusinessresearchcompany.com/report/topical-wound-agents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795